Advertisement
Advertisement
Trending on Pharmacy Times
1
Early IVIG Use Associated With Reduced Infections and Improved Survival in Patients Receiving Talquetamab for Multiple Myeloma
2
Camizestrant Plus CDK4/6 Inhibitor Demonstrates Sustained Benefit Beyond First Progression in ESR1-Mutated Breast Cancer
3
FDA Grants Priority Review to Bezuclastinib Plus Sunitinib for Patients With Advanced GIST
4
Real-World Data Reveals Opportunities to Improve HER2-Low Metastatic Breast Cancer Care
5